Business context and reporting period
Important identity discrepancy: The supplied filing is MoSys, Inc.’s Form 10-Q for the quarter ended September 30, 2015—not a Peraso Inc. filing. This summary reflects the filing text provided.
MoSys develops and sells fabless semiconductor ICs for networking and communications markets, including Bandwidth Engine and LineSpeed products, and has legacy IP royalty revenue. The unaudited results cover the three and nine months ended September 30, 2015, compared with the same periods in 2014.
Financial highlights
Amounts below are in millions except per-share data and percentages.
| Metric | Q3 2015 | Q3 2014 | 9M 2015 | 9M 2014 |
|---|---|---|---|---|
| Revenue | $1.022 | $1.153 | $2.792 | $4.234 |
| Gross profit / margin | $0.229 / 22% | $0.706 / 61% | $1.199 / 43% | $2.188 / 52% |
| Operating loss | $(10.111) | $(8.490) | $(24.987) | $(23.781) |
| Net loss | $(10.105) | $(8.483) | $(24.976) | $(23.731) |
| Net loss per share | $(0.15) | $(0.17) | $(0.41) | $(0.48) |
| Operating cash flow | Not separately provided for the quarter | $(23.122) | $(18.711) |
- Q3 product revenue rose 29% to $0.565 million, but royalty and other revenue fell 36% to $0.457 million. Nine-month total revenue declined 34%, with product revenue down 35% and royalty and other revenue down 33%.
- Q3 cost of revenue increased 77% to $0.793 million; the filing cites higher IC shipments and a $0.2 million slow-moving inventory provision. Nine-month cost of revenue declined 22% to $1.593 million, partly reflecting lower shipments.
- Research and development expense was $8.793 million in Q3, up 17%, and $21.475 million for nine months, up 2%. SG&A decreased 8% in Q3 and 5% for nine months.
- At September 30, cash and cash equivalents were $1.585 million and investments were $23.866 million, totaling about $25.5 million. Working capital was $23.8 million. Total liabilities were $2.684 million, including $0.249 million of long-term liabilities; the filing does not identify borrowings or provide a clear debt balance.
- Cash used in investing activities was $1.544 million for nine months, including $0.369 million of property and equipment purchases. Financing provided $23.141 million, chiefly from a March equity offering.
Material changes versus the prior period
- Revenue and gross profit fell year over year for both Q3 and the first nine months; Q3 gross margin contracted to 22% from 61%.
- Despite a larger absolute net loss, reported loss per share was lower, reflecting a higher weighted-average share count. The company sold 14.375 million shares in March 2015, raising about $21.4 million net; shares outstanding were 65.496 million at September 30, versus 49.793 million at year-end 2014.
- Nine-month operating cash use increased by $4.411 million year over year. Cash and cash equivalents declined from $3.110 million at year-end, while investments increased.
Outlook, risks and unusual items
- Management expects cash expenditures to exceed receipts for the foreseeable future and says additional funding will be needed to maintain current spending. An effective shelf registration permits sales of up to approximately $27 million of securities before September 2017; equity issuance would dilute shareholders, while debt financing could impose restrictive terms.
- Management reports approximately 25 customers and more than 70 design wins, and expects earlier design wins to ramp into production. It cautions that revenue contribution and ramp rates cannot be estimated reliably and that future volume pricing may differ from initial pricing. No specific revenue or earnings guidance is provided.
- R&D spending is expected to fluctuate with mask tooling and fabrication costs. Key uncertainties include product-market adoption, shipment levels, manufacturing yields and costs, collections, and access to financing.
- Two customers represented 68% of Q3 revenue; one customer accounted for 76% of net receivables at quarter-end. Customer concentration is a notable exposure.
- Under the Credo development and marketing agreement, MoSys had paid $4.7 million and was entitled to recover $3.6 million from product gross profits; initial profits primarily reimburse MoSys, after which gross profits are shared equally. The filing reports a $0.2 million inventory provision. Goodwill was $23.134 million; the September 2015 impairment assessment found no impairment indicators.
- The company reported no material legal proceeding it believed likely to materially harm its financial position or results. Management concluded disclosure controls were effective and reported no material third-quarter change in internal control over financial reporting.
Important facts for investors to verify
- Confirm the registrant: the provided document names MoSys, Inc., while the request identifies Peraso Inc.
- Track revenue conversion from design wins, shipment growth, royalty trends, and the timing and effect of customer pricing negotiations.
- Assess operating cash burn against the $25.5 million cash-and-investment balance and the availability and dilution impact of additional financing.
- Monitor customer concentration, inventory quality and reserves, and Credo product economics and reimbursement terms.
- Review the underlying filing and subsequent reports for updated financial results, liquidity, contingencies, and any changes to the outlook.